Development of gemcitabine-resistant patient-derived xenograft models of pancreatic ductal adenocarcinoma

Aim: Gemcitabine is a frontline agent for locally-advanced and metastatic pancreatic ductal adenocarcinoma (PDAC), but neither gemcitabine alone nor in combination produces durable remissions of this tumor type. We developed three PDAC patient-derived xenograft (PDX) models with gemcitabine resistan...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Drug Resist
Main Authors: Miller, Aubrey L., Garcia, Patrick L., Gamblin, Tracy L., Vance, Rebecca B., Yoon, Karina J.
Format: Artigo
Sprog:Inglês
Udgivet: OAE Publishing Inc. 2020
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7561044/
https://ncbi.nlm.nih.gov/pubmed/33073205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/cdr.2020.35
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker